日期: 2026-04-09
代码: 1875.HK
事件: 股东增减持（股东增减持）
药明生物于2026-04-09场外减持621.7万股，每股均价4港元，最新持股数目4.689亿股，最新持股比例60.67% @#$ WuXi XDC Cayman Inc., a direct subsidiary of WuXi Biologics (Cayman) Inc., as part of the Post-Completion Transfer, completed the sale of 5,180,450 Shares to Center Laboratories and 1,036,090 Shares to Advantech Capital Investment, each for HK$4.0 per Share, on 9 April 2026. For more information, and for the definitions of capitalised terms in this paragraph, please refer to the announcement jointly issued by WuXi XDC Cayman Inc. and BioDlink International Company Limited dated 31 March 2026.